Navigation Links
Archimedes Inc. Renews Annual Marketing Agreement with HealthEconomics.Com
Date:3/18/2013

Ponte Vedra Beach, FL (PRWEB) March 18, 2013

HealthEconomics.Com, recognized for nearly 20 years as the #1 ranked website in health economics, and Archimedes Inc., a healthcare modeling and analytics company, announce plans to continue their digital marketing partnership for 2013. Archimedes is the creator of the Archimedes Model, a carefully validated, clinically-realistic simulation model of health and healthcare.

Archimedes provides researchers, medical professionals, policy makers and executives a valuable alternative to real world clinical research that cannot be studied empirically due to cost, duration, ethics, complexity, number of variables, or urgency. The Archimedes Model can simulate populations, diseases and interventions to create forecast datasets with a high degree of realism and accuracy. Based on current scientific evidence, that is regularly updated and validated, the Archimedes Model can run a virtual clinical trial with 1,000,000 people, spanning 20 years of life in 3 hours.

The HealthEconomics.Com Annual Marketing Partnership Program allows partners to communicate with a global community of 20,000 pharmaceutical, health outcomes research, pricing and reimbursement professionals by offering a tested array of digital marketing solutions. To date, 26 Annual Marketing Partners have signed with HealthEconomics.Com with >90%, like Archimedes Inc., renewing their partnerships for multiple years.

“Archimedes decision to partner with HealthEconomics.Com for a third consecutive year provides us a wonderful opportunity to work with a company that has pioneered health and healthcare modeling systems,” says Dr. Patti Peeples, President and founder of HealthEconomics.Com. “By using the Archimedes Model, researchers can analyze a variety of questions across a large number of biomarkers and interventions, sidestepping the enormous costs, difficulty in obtaining participants, and the investment of time required in real world trials. We look forward to our continued association with Archimedes, and the challenge of promoting the services they offer by creating effective, innovative communication channels that provide access to our global audience of HEOR professionals.”

Archimedes Inc. is located in San Francisco, and was founded by Len Schlessinger, Ph.D, and David Eddy, MD, Ph.D, a pioneer in evidence-based decision making. The Archimedes Model serves as the foundation of innovations such as ARCHeS, the online population simulation and analytics suite and IndiGO, a patient and physician decision support tool to help people understand the implications of their decisions.. For more information on these products, visit the website at http://www.archimedesmodel.com.

About HealthEconomics.Com (http://www.healtheconomics.com): A pioneer in the field, HealthEconomics.Com is the global authority in healthcare value and pharma market access. Each day, HealthEconomics.Com compiles the latest news, policy updates, resources, conferences, and jobs for BioPharma’s professionals involved in health economics, outcomes research, market access, and pricing. A trusted resource, HealthEconomics.Com’s comprehensive content is carefully selected by a discerning health economist editor, making it the most visited website for healthcare value and market access in the industry, with visitors encompassing all corners of the globe.

News Media interested in receiving the most current information on healthcare value and market access may obtain a free subscription to HealthEconomics.Com by visiting the site or by subscribing to the HealthEconomics.Com Newsletter.

Read the full story at http://www.prweb.com/releases/2013/3/prweb10537437.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Pharmalink AB Gains Exclusive Licence to Archimedes Pharmas TARGIT® Technology for Nefecon® (PL-56) Program
2. NSBRI Renews Space Life Sciences Graduate Programs at MIT, Texas A&M
3. Mindray Renews Agreement with HealthTrust Purchasing Group, L.P. to Provide Patient Monitoring Equipment
4. Palatin Technologies To Present At The 25th Annual ROTH Conference
5. Keryx Biopharmaceuticals to Present at the 25th Annual ROTH Conference
6. Astute Medical, Inc. ospiterà il simposio sullinsufficienza renale al 33o incontro annuale ISICEM
7. Annual Conference about Technology Solutions for People with Disabilities Announces Program
8. Senomyx To Webcast Corporate Presentation At The 25th Annual ROTH Conference
9. Verenium To Present At The 25Th Annual Roth Conference
10. Abacus International Expands Annual Partnership With HealthEconomics.Com
11. OHK Medical Devices to Exhibit at 2013 AAOS Annual Meeting (Booth 1108) on March 20-22, 2013 in Chicago
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... and MENLO PARK, Calif. , ... DMPI) ("DelMar" and the "Company"), a biopharmaceutical company focused on ... that it will present at the 18 th ... 8, 2016 at 10:00 a.m. EST in New ... DelMar,s president and CEO, will provide an update on the ...
(Date:2/4/2016)... , Feb. 4, 2016  Spherix Incorporated (Nasdaq: ... the fostering and monetization of intellectual property, today provided ... Uniden in the Northern District of Texas ... forward.  Inter Partes Re-examination ("IPR") ... Patent Office.  The IPR was initiated on only certain ...
(Date:2/4/2016)... Strasbourg, France , to the US ... Strasbourg, France , to the US company Advanced Bioscience ... announce that it acted as an advisor to Transgene on ... Strasbourg, France , to the US company Advanced Bioscience ... Transgene (Euronext: TNG), a member of Institut Mérieux, is ...
(Date:2/3/2016)... , Feb. 3, 2016  Discovery Laboratories, Inc. ... on developing aerosolized KL4 surfactant therapies for respiratory ... has approved an inducement award as a component ... its newly appointed President and Chief Executive Officer.  ... Committee on February 1, 2016 and granted as ...
Breaking Biology Technology:
(Date:1/8/2016)... MANCHESTER, United Kingdom , Jan. 8, 2016 /PRNewswire/ ... sensor-based diagnostic products, today announced the closing of a $9 ... investors.  Proceeds from the financing will be used to accelerate ... device for detecting early-stage pressure ulcers. ... after receiving CE Mark approval. The device,s introduction has been ...
(Date:1/7/2016)... , Jan. 7, 2016 Various factors ... biopharmaceutical products such as biologics and biosimilars. Some ... reduce healthcare expenditure, growing demand for cost-effective alternatives, ... population. Biosimilars are similar versions of their corresponding ... to their quality, safety, and efficacy. The global ...
(Date:1/6/2016)... Jan. 6, 2016 Based on its ... & Sullivan recognizes MorphoTrak, LLC, a U.S. subsidiary ... Frost & Sullivan Company of the Year Award. ... technology, Morpho Wave™ , has consolidated the company,s ... biometrics market. Morpho Wave is a highly ...
Breaking Biology News(10 mins):